Targeted Sequencing of Mixed Neuroendocrine- Non-neuroendocrine Neoplasm of the Gallbladder Suggests a Monoclonal Origin
A Case Report
DOI:
https://doi.org/10.21141/PJP.2019.16Keywords:
gallbladder, MiNEN, molecular analysisAbstract
Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) of the gallbladder is a rare tumor that is defined in the World Health Organization (WHO) 2019 digestive system tumor classification as the presence of a neuroendocrine neoplasm admixed with a non-neuroendocrine carcinoma, each component constituting at least 30% of the neoplasm. The exact pathogenesis of MiNENs remains unclear. We present a case of a 74-year-old Filipino woman who presented with nonspecific clinical and radiologic findings and subsequently underwent cholecystectomy. Histopathologic and immunohistochemical evaluation of the gallbladder confirmed the diagnosis of a mixed well-differentiated adenocarcinoma (30%) and large cell neuroendocrine carcinoma (70%). The adenocarcinoma and neuroendocrine carcinoma components were separately microdissected and submitted for targeted 15-gene sequencing using the Illumina Trusight Tumor 15 (TST15) panel. NGS identified a TP53 missense mutation leading to a stop codon in both components. The finding of similar molecular signatures in the two morphologically distinct components supports the hypothesis that MiNEN arises from a common precursor stem cell capable of divergent phenotypic differentiation.
Downloads
References
2. Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO classification of tumour of the digestive system, 5th edition. Lyon: IARC Press, 2019.
3. Miyamoto R, Kikuchi K, Uchida A, et al. Large cell neuroendocrine carcinoma of the gallbladder: a case report and literature review. Int Surg. 2016;101:458-64. https://doi.org/10.9738/10.9738/INTSURG-D-16-00122.1.
4. Acosta AM, Wiley EL. Primary biliary mixed adenoneuroendocrine carcinoma (MANEC): a short review. Arch Pathol Lab Med. 2016;140(10):1157-62. https://pubmed.ncbi.nlm.nih.gov/27684986. https://doi.org/10.5858/arpa.2015-0102-RS.
5. Jung J, Chae YS, Kim CH, et al. Combined adenosquamous and large cell neuroendocrine carcinoma of the gallbladder. J Pathol Transl Med. 2018;(52):121-5. https://pubmed.ncbi.nlm.nih.gov/28994275. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859238. https://doi.org/10.4132/jptm.2017.08.20.
6. Chen XS, Xie XF, Zhou JJ. Mixed large cell neuroendocrine carcinoma and adenosquamous carcinoma of gallbladder: a case report. Int J Clin Exp Pathol 2017;10(2):1882-5. http://www.ijcep.com/files/ijcep0042195.pdf.
7. Skalický A, Vištejnová L, Dubová M, Malkus T, Skalický T, Troup O. Mixed neuroendocrine-non-neuroendocrine carcinoma of gallbladder: case report. World J Surg Oncol. 2019;17. https://doi.org/10.1186/s12957-019-1598-4.
8. De Mestier L, Cros J. Digestive system mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN). Ann Endocrinol (Paris). 2019;80(3):172–3. https://pubmed.ncbi.nlm.nih.gov/31064662. https://doi.org/10.1016/j.ando.2019.04.006.
9. Goldblum JR, Odze RD. Odze and Goldblum Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas. Philadelphia, PA: Elsevier Saunders, 2015.
10. Eltawil KM, Gustafsson BI, Kidd M, Modlin IM. Neuroendocrine tumors of the gallbladder: an evaluation and reassessment of management strategy. J Clin Gastroenterol. 2010;44(10):687-95. https://pubmed.ncbi.nlm.nih.gov/20375728. https://doi.org/10.1097/MCG.0b013e3181d7a6d4.
11. Mills SE. Histology for Pathologists. Fourth ed. Philadelphia, PA: Wolters Kluwer, 2012.
12. Buscemi S, Orlando E, Damiano G, et al. "Pure" large cell neuroendocrine carcinoma of the gallbladder: report of a case and review of the literature. Int J Surg. 2016; 28(Suppl 1): S128-32. https://pubmed.ncbi.nlm.nih.gov/26708705. https://doi.org/10.1016/j.ijsu.2015.12.045.
13. Paniz Mondolfi AE, Slova D, Fan W, et al. Mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: a possible stem cell tumor? Pathol Int. 2011;61(10):608-14. https://pubmed.ncbi.nlm.nih.gov/21951672. https://doi.org/10.1111/j.1440-1827.2011.02709.x.
14. Diamantis I. Karamitopoulou E, Perentes E, Zimmermann A. p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival. Hepatology. 1995;22(3):774-9. https://pubmed.ncbi.nlm.nih.gov/7657282.
15. Sato K, Imai T, Shirota Y, Ueda Y, Katsuda S. Combined large cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. Pathology Res Pract. 2010;206(6):397-400. https://pubmed.ncbi.nlm.nih.gov/19945229. https://doi.org/10.1016/j.prp.2009.10.008.
16. Javle M, Rashid A, Churi C, et al. Molecular characterization of gallbladder cancer using somatic mutation profiling. Hum Pathol. 2014;45(4):701-8. https://pubmed.ncbi.nlm.nih.gov/24508317. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428571. https://doi.org/10.1016/j.humpath.2013.11.001.
Downloads
Published
How to Cite
Issue
Section
License
The Philippine Journal of Pathology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on works made open access at http://philippinejournalofpathology.org
@philippinepathologyjournal